Turkey
Farmasol Tibbi is a specialty pharmaceutical company that specializes in developing and commercializing Hemodialysis products with a focus on improving the health of individuals undergoing dialysis therapy. Established in 2004 and headquartered in Turkey, Farmasol is committed to delivering specialized solutions for this particular market segment.
The company's slogan underlines its dedication to providing "Specialized solutions designed for individuals undergoing dialysis therapy." Farmasol's description emphasizes its belief in the business advantages of concentrating on Hemodialysis products, backed by proven expertise and a focus on exceptional performance. Their vision is centered around leveraging their expertise in Hemodialysis to make a significant impact on patient health, aligning with the company's mission to serve the millions of patients awaiting the benefits of their products and services.
Farmasol Tibbi operates within the Digital Health, Health Care, Health and Wellness, and Healthtech industries, positioning itself in dynamic and fast-growing sectors with high potential for impact and growth. While specific details about their last investment and investors are not currently available, Farmasol's clear focus and specialized approach make it a noteworthy player in the healthcare and pharmaceutical landscape.
